A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for the drugs, which often retail at more than $1,000 ...

100% of the fees we collect are used to support our nonprofit mission. Learn more. O bstructive sleep apnea (OSA), marked by numerous pauses in breathing during sleep, can cause daytime ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

A flight passenger who boarded a late-night flight out of Atlanta, Georgia, shared frustrations about the baggage-related actions of some fellow flyers. Posting in the "r/delta" Reddit forum with ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Ariona State head coach Kenny Dillingham stands on ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...

After Nick Saban announced his retirement from college football following the 2023 season, only four coaches who had won a national championship remained active in college football. However ...

Over the past few years, demand for blockbuster medications like Ozempic, Wegovy and Zepbound skyrocketed. These drugs are typically prescribed to address a range of health issues, including ...

Much of the debate centered on whether the city’s case sought to restrict emissions. Mr. Sher said Charleston’s goal was not to limit emissions, but rather to generate money to help cover the ...

Credit: Getty Images With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management. In recent years ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea (OSA). AD109 is a once daily pill that consists of ...